AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Kovalchuk, O Arkhipov, A Barylyak, I Karachov, I Titov, V Hohn, B Kovalchuk, I
Citation: O. Kovalchuk et al., Plants experiencing chronic internal exposure to ionizing radiation exhibit higher frequency of homologous recombination than acutely irradiated plants, MUT RES-F M, 449(1-2), 2000, pp. 47-56

Authors: Kaufmann, M Bajetta, E Dirix, LY Fein, LE Jones, SE Zilembo, N Dugardyn, JC Nasurdi, C Mennel, RG Cervek, J Fowst, C Polli, A di Salle, E Arkhipov, A Piscitelli, G Miller, LL Massimini, G
Citation: M. Kaufmann et al., Exemestane is superior to megestrol acetate after tamoxifen failure in postmenopausal women with advanced breast cancer: Results of a phase III randomized double-blind trial, J CL ONCOL, 18(7), 2000, pp. 1399-1411

Authors: Lonning, PE Bajetta, E Murray, R Tubiana-Hulin, M Eisenberg, PD Mickiewicz, E Celio, L Pitt, P Mita, M Aaronson, NK Fowst, C Arkhipov, A di Salle, E Polli, A Massimini, G
Citation: Pe. Lonning et al., Activity of exemestane in metastatic breast cancer after failure of nonsteroidal aromatase inhibitors: A phase II trial, J CL ONCOL, 18(11), 2000, pp. 2234-2244

Authors: Beresford, NA Gashchak, S Lasarev, N Arkhipov, A Chyorny, Y Arkhipov, N Mayes, RW Howard, BJ Baglay, G Loginova, L Burov, N
Citation: Na. Beresford et al., The transfer of Cs-137 and Sr-90 to dairy cattle fed fresh herbage collected 3.5 km from the Chernobyl nuclear power plant, J ENV RAD, 47(2), 2000, pp. 157-170

Authors: Kovalchuk, O Dubrova, YE Arkhipov, A Hohn, B Kovalchuk, I
Citation: O. Kovalchuk et al., Germline DNA - Wheat mutation rate after Chernobyl, NATURE, 407(6804), 2000, pp. 583-584

Authors: Kovalchuk, O Kovalchuk, I Titov, V Arkhipov, A Hohn, B
Citation: O. Kovalchuk et al., Radiation hazard caused by the Chernobyl accident in inhabited areas of Ukraine can be monitored by transgenic plants, MUT RES-GTE, 446(1), 1999, pp. 49-55

Authors: Jones, S Vogel, C Arkhipov, A Fehrenbacher, L Eisenberg, P Cooper, B Honig, S Polli, A Whaley, F di Salle, E Tiffany, J Consonni, A Miller, L
Citation: S. Jones et al., Multicenter, phase II trial of exemestane as third-line hormonal therapy of postmenopausal women with metastatic breast cancer, J CL ONCOL, 17(11), 1999, pp. 3418-3425
Risultati: 1-7 |